202 related articles for article (PubMed ID: 30464675)
1. Evolving role of pharmaceutical physicians in medical evidence and education.
Setia S; Ryan NJ; Nair PS; Ching E; Subramaniam K
Adv Med Educ Pract; 2018; 9():777-790. PubMed ID: 30464675
[TBL] [Abstract][Full Text] [Related]
2. Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan.
Maeda H
Front Med (Lausanne); 2021; 8():672095. PubMed ID: 34434941
[TBL] [Abstract][Full Text] [Related]
3. Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry.
Jandhyala R
F1000Res; 2022; 11():813. PubMed ID: 36415210
[No Abstract] [Full Text] [Related]
4. Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument.
Jandhyala R
Pharmaceut Med; 2022 Feb; 36(1):47-57. PubMed ID: 34994965
[TBL] [Abstract][Full Text] [Related]
5. Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety.
Blum AB; Shea S; Czeisler CA; Landrigan CP; Leape L
Nat Sci Sleep; 2011; 3():47-85. PubMed ID: 23616719
[TBL] [Abstract][Full Text] [Related]
6. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
7. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
Kato M; Ishikawa H; Okuhara T; Kiuchi T
Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
10. Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.
Jandhyala R
Front Pharmacol; 2022; 13():842431. PubMed ID: 35273511
[No Abstract] [Full Text] [Related]
11. Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.
Sampalis JS; Watson J; Boukas S; Boukas M; Harvey N; Machado S; Bordeleau M; Rampakakis E
Surgery; 2017 Mar; 161(3):576-583. PubMed ID: 28190508
[TBL] [Abstract][Full Text] [Related]
12. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
D'Hooghe T
Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
[TBL] [Abstract][Full Text] [Related]
13. Clinical conferences for physicians: Who sets the agenda?
Abakumova TR; Safina AF; Ziganshina LE
Int J Risk Saf Med; 2015; 27 Suppl 1():S91-2. PubMed ID: 26639730
[TBL] [Abstract][Full Text] [Related]
14. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
Coleman DL; Kazdin AE; Miller LA; Morrow JS; Udelsman R
Acad Med; 2006 Feb; 81(2):154-60. PubMed ID: 16436576
[TBL] [Abstract][Full Text] [Related]
16. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
F1000Res; 2018; 7():111. PubMed ID: 30026923
[TBL] [Abstract][Full Text] [Related]
17. [Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].
Miyata Y
Seishin Shinkeigaku Zasshi; 2010; 112(11):1136-45. PubMed ID: 21226250
[TBL] [Abstract][Full Text] [Related]
18. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
Pittet AL; Saraga M; Stiefel F
Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
[TBL] [Abstract][Full Text] [Related]
19. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
